Northwell Health Named One of America’s Most Innovative Companies by Fortune

Northwell Health has been named one of America’s Most Innovative Companies 2023 by Fortune. New York State’s largest health care provider and private employer is one of just 300 companies nationwide to make the list.

The award is presented by Fortune and Statista Inc., the world-leading statistics portal and industry ranking provider. Recipients were chosen based on evaluations about their innovation culture, as well as product and process innovation. Statista compiled scores based on surveys done by employees, as well as outside experts.

“Innovation is part of who we are at Northwell,” said Michael Dowling, president and chief executive officer of Northwell. “The COVID-19 pandemic proved that our team is ready to meet whatever challenges arise. We are always looking for new treatments and methods of care to give our patients the best results possible.”

Northwell ranked 202 on the list overall, which evaluated companies based on three categories: product innovation, process innovation and innovation culture.

Northwell Health was on the front lines of the COVID-19 pandemic, conducting thousands of clinical trials at the Feinstein Institutes for Medical Research, innovated lab testing for the disease and was instrumental in getting employee and community vaccination programs running throughout the region.

Innovation abounds at Northwell’s Feinstein Institutes for Medical Research, which received multimillion dollar grants in 2022 to study and map the vagus nerve. The Feinstein Institutes are the global home of scientific research into bioelectric medicine, which combines molecular medicine, neuroscience and biomedical engineering. The research is used to develop new devices to help treat disease and injury.

“Innovation is a team sport at Northwell. Our core strength comes from the curiosity and ingenuity of our 83,000 team members,” said Jason Naidich, MD, Northwell’s senior vice president and chief innovation officer. “There is a role for everyone whether in process improvement, clinical care redesign, research, or development of digital technology and medical devices.”

Being named one of the most innovative companies in America is the latest in a long line of accolades for Northwell. Last year, Northwell was named both one of the Best Workplaces in Healthcare and one of the Best Companies to Work For by Fortune. It ranked third on Fast Company’s list of the World’s Most Innovative Companies. Northwell was also the No. 1 health system in the Best Workplaces in New York 2022 list by Great Places to Work.

Northwell is a national leader in LGBTQ inclusiveness, according to 2022 Healthcare Equality Index, was recognized on the 2022 PEOPLE Companies that Care list and has been rated the No. 1 health system for diversity in the country three years running by DiversityInc. Most recently, Northwell was named one of the World’s Most Ethical Companies for 2023 by Ethisphere.

To see the full list of Fortune’s Most Innovative Companies 2023, go to: https://fortune.com/ranking/americas-most-innovative-companies/2023/search/

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”